How much funding has Torpedo Therapeutics raised?

Torpedo Therapeutics has raised $920K in total funding, most recently a Venture Round.

Who are Torpedo Therapeutics's investors?

Torpedo Therapeutics's investors include SBXi, Y Combinator Continuity Fund.

When was Torpedo Therapeutics founded?

Torpedo Therapeutics was founded in 2018.

Where is Torpedo Therapeutics headquartered?

Torpedo Therapeutics is headquartered in Boston, Massachusetts, United States.

What industry is Torpedo Therapeutics in?

Torpedo Therapeutics operates in Biotech, Healthcare, Medical Devices, Neurotechnology.

How many employees does Torpedo Therapeutics have?

Torpedo Therapeutics has 1-10 employees.

Torpedo Therapeutics

High-precision, closed-loop neuromodulation devices

Boston, United States · Founded 2018 · $920K raised

YC W22

Headquarters: Boston, Massachusetts
Employees: 1–10
Founded: 2018
Website: torpedotherapeutics.com

Total Funding: $920K
Last Round: $920K Venture RoundMar 2022
Rounds: 1

About

We are building high-precision implantable neuromodulation devices that can sense and stimulate neural activity in the brain with the goal of transforming the efficacy and adoption of deep brain stimulation (DBS), an existing FDA-approved therapy used to treat Parkinson’s, essential tremor and epilepsy.

Summary

Torpedo Therapeutics is a Biotech company based in Boston, United States, founded in 2018. It has raised $920K in total across 1 round, most recently a $920K Venture Round round in Mar 2022. Investors include SBXi and Y Combinator Continuity Fund.